undamentalytics Newsletter
Sign in

Core Laboratories Inc. balance sheet

At the end of fiscal 2025, Core Laboratories Inc. had total assets of $584m and shareholders' equity of $266m. It held $22.7m in cash against $113m of debt: net debt of $90.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents181515192321
Receivables—107109112114116
Inventory—6072595461
Total current assets—212223221215225
Goodwill—999999106106
Total assets581578586585584594
Accounts payable—4634353740
Deferred revenue (current)—101——
Total current liabilities—10388102106103
Long-term debt—172163126110112
Total debt0175166128113115
Shareholders' equity161184225247266278
Net debt (negative = net cash)−181601511099093
Shares outstanding—47m47m47m46m46m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CLB vs RNGRBOOM vs CLBCLB vs KLXE

More: Oil & Gas Equipment & Services stocks compared, Energy sector, rankings of US companies

Figures from Core Laboratories Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Core Laboratories Inc.